MARIA CARTAGENA: Open Payments
NPI 1083617815 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,433 in 61 payments from 18 companies in 2025. Trend: 2023 $1,220 · 2024 $484 · 2025 $1,433
Food & beverage: $1,433
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $205 |
| Neurocrine BioSciences, Inc. | 8 | $196 |
| Otsuka America Pharmaceutical, Inc. | 10 | $183 |
| Teva Pharmaceuticals USA, Inc. | 10 | $140 |
| Janssen Scientific Affairs, LLC | 1 | $131 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $89 |
| Janssen Pharmaceuticals, Inc | 4 | $83 |
| Lundbeck LLC | 4 | $71 |
| Alkermes, Inc. | 3 | $59 |
| ABBVIE INC. | 3 | $57 |
Products named: REXULTI, FANAPT, INGREZZA, AUSTEDO XR, INVEGA SUSTENNA, CAPLYTA, SPRAVATO, ARISTADA.
Industry payments across NY — which companies pay providers there.
